Literature DB >> 30936525

Enzymatic anti-CRISPRs improve the bacteriophage arsenal.

Shravanti K Suresh1, Karthik Murugan1, Dipali G Sashital2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30936525      PMCID： PMC6643262          DOI： 10.1038/s41594-019-0210-5

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN： 1545-9985            Impact factor:   15.369


× No keyword cloud information.
  1 in total

1.  Broad-spectrum enzymatic inhibition of CRISPR-Cas12a.

Authors:  Gavin J Knott; Brittney W Thornton; Marco J Lobba; Jun-Jie Liu; Basem Al-Shayeb; Kyle E Watters; Jennifer A Doudna
Journal:  Nat Struct Mol Biol       Date:  2019-04-01       Impact factor: 15.369
  1 in total
  2 in total

1.  Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a.

Authors:  Gavin J Knott; Brady F Cress; Jun-Jie Liu; Brittney W Thornton; Rachel J Lew; Basem Al-Shayeb; Daniel J Rosenberg; Michal Hammel; Benjamin A Adler; Marco J Lobba; Michael Xu; Adam P Arkin; Christof Fellmann; Jennifer A Doudna
Journal:  Elife       Date:  2019-08-09       Impact factor: 8.140

Review 2.  Anti-CRISPRs: The natural inhibitors for CRISPR-Cas systems.

Authors:  Fei Zhang; Guoxu Song; Yong Tian
Journal:  Animal Model Exp Med       Date:  2019-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.